<DOC>
	<DOCNO>NCT02182791</DOCNO>
	<brief_summary>Study determine effect nevirapine treatment pharmacokinetics ethinyl estradiol ( EE ) /norethindrone ( NET ) .</brief_summary>
	<brief_title>Investigation Potential Pharmacokinetic Interaction Between Nevirapine ( VIRAMUNE ) Ethinyl Estradiol/Norethindrone HIV-1 Infected Women</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Mestranol</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Norethindrone acetate , ethinyl estradiol , ferrous fumarate drug combination</mesh_term>
	<mesh_term>Norinyl</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<criteria>Female patient age 18 65 year Plasma HIV1 RNA &lt; = 400 copies/mL , document HIV1 infection , within 28 day prior Study Day 0 Lymphocytes Expressing CD4+ Surface Marker ( CD4+ cell count ) &gt; = 100 cells/mm続 within 28 day prior Study Day 0 Patients meet follow laboratory parameter : Lymphocyte count &gt; = 1000 cells/mm続 Hemoglobin &gt; = 9.0 g/dl ( men woman ) Platelet count &gt; = 75000 cells/mm3 Alkaline Phosphatase &lt; = 3.0 time upper limit normal Serum GlutamicOxaloacetic Transaminase ( SGOT ) Serum GlutamicPyruvic Transaminase ( SGPT ) &lt; = 3.0 time upper limit normal Total bilirubin &lt; = 1.5 time upper limit normal Creatinine &lt; = 2mg/dL Female patient reproductive potential must willing use reliable method doublebarrier contraception ( diaphragm spermicidal cream jelly , condom spermicidal foam ) Patients inform willing able comply investigational nature study sign write consent accordance institutional federal guideline Patients stable antiretroviral therapy ( change medication dose ) least thirty day prior study entry continue background study participation Female patient pregnant breastfeed Patients require systemic treatment corticosteroid drug know hepatic enzyme inducer inhibitor within 14 day stud entry ( Study Day 0 ) . Such substance category include : macrolide antibiotic ( erythromycin , clarithromycin ) , azole antifungal ( ketoconazole , fluconazole , itraconazole ) rifampin , rifabutin , phenytoin Patients receive investigational drug within 30 day first dose study medication antineoplastic agent radiotherapy local skin radiotherapy treatment within 12 week start study medication Patients malabsorption , severe chronic diarrhea patient unable maintain adequate oral intake Patients history intravenous drug abuse , alcohol substance abuse consider Investigator Boehringer Ingelheim Pharmaceutical Incorporated ( BIPI ) Medical Monitor significant impairment health compliance Patients undergoing treatment active infection Patients hepatic insufficiency due cirrhosis Patients renal insufficiency Patients heavy smoker ( e.g . &gt; 20 cigarette per day ) Patients currently take Norvir速 ( Ritonavir ) Rescriptor速 ( Delavirdine )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>